Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-23
1998-05-05
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 514824, 536 185, 536115, 5361231, 536 2, A61K 31705, A61K 31715, C08B 3706
Patent
active
057474648
ABSTRACT:
A composition for inhibiting absorption of fat and cholesterol from the gut and a method for making and using the composition. The composition comprises .beta.-sitosterol bound irreversibly to pectin to form a .beta.-sitosterol/pectin complex.
REFERENCES:
patent: 3881005 (1975-04-01), Thakkar et al.
patent: 4865850 (1989-09-01), Shell et al.
patent: 5112815 (1992-05-01), Ambrus et al.
patent: 5244887 (1993-09-01), Straub
patent: 5277910 (1994-01-01), Hidvegi
patent: 5384400 (1995-01-01), Crescenzi et al.
Carbohydrate Chemistry, Ed. John F. Kennedy, Clarendon Press, pp. 233-235 & 620-622, (1988).
Oster et al., Dtsch. Med. Wschr., vol. 101/36, pp. 1308-1311, (1976) Abstract only.
Pirich et al., Wien Klin. Wochenschr., vol. 104(11), pp. 314-316, (1992) Abstract only.
Sable-Amplis et al., Med. Sci. Res., vol. 16(9), pp. 453-454, (1988) Abstract only.
Lu et al. Nutritional Research (N.Y. ) vol. 9(3): 345-352, (1989).
Vanhanen, H. et al., Effects of Sitostanol Ester, Dissolved in Dietary Oil, on Serum Cholesterol, Plant Sterols and Cholesterol Precursors, Second Department of Medicine, University of Helsinki, Helsinki, Finland, Circulation Supplement II, Abstracts From the 64th Scientific Sessions, 2389, Oct. 91.
Nicolosi, R.J., Beyond Fatty Acids, Department of Clinical Sciences, University of Massachusetts Lowell, Lowell, MA 01854, Circulation, vol. 85, No. 2, Feb. 1992.
Haskell, W. L., Role of Water-Soluble Dietary Fiber in the Management of Elevated Plasma Cholesterol in Healthy Subjects, The American Journal of Cardiology, Feb. 15, 1992, vol. 69, No. 5, pp. 433-437.
Hospital Pharmacology Goodman and Gilman: The Pharmacological Basis of Therapeutics 7th Edition, 1985, p. 843.
Briones, Esperanza R., Primary Hypercholesterolemia: Effect of Treatment on Serum Lipids, Lipoprotein Fractions, Cholesterol Absorption, Sterol Balance, and Platelet Aggregation, Mayo Clin Proc, Apr. 1984, vol. 59, pp. 251-257.
Kane, John P. et al., Treatment of Hypercholesterolemia, Medical Clinics of North America--vol. 66, No. 2, Mar. 1992, pp. 537-550.
Merck Manual, Skimmin, 1983, p. 1227.
Gundy, Scott M. et al., Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia, J. Lab. Clin Med, Feb. 1977, pp. 354-366.
Strocchi, Alessandra, et al., An understanding of absorptive physiology facilitates prompt recognition of signs and symptoms of malabsorption, use and interpretation of diagnostic tests, and selection of specialized tests to determine the etiology, Contemporary Internal Medicine, Apr. 1992, pp. 91-110.
Ripsin, Cynthia M., et al., Oat Products and Lipid Lowering, JAMA, Jun. 24, 1992-vol. 267, No. 24, pp. 3317-3325.
Cerda, J.J. et al., The Effects of Grapefruit Pectin and Patients at Risk for Coronary Heart Disease Without Altering Diet or Lifestyle, Clin. Cardiol. vol. 11, pp. 589-594 (1988).
Baekey, P.A. et al., Grapefruit Pectin Inhibits Hypercholesteroleima and Atherosclerosis in Miniature Swine, Clin. Cardiol. vol. 11, pp. 595-600 (1988).
Bio-Sphere Technology, Inc.
Kight John
Lee Howard C.
LandOfFree
Dietary supplement incorporating .beta.-sitosterol and pectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary supplement incorporating .beta.-sitosterol and pectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplement incorporating .beta.-sitosterol and pectin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54643